BLOODGENETICS signed a collaboration agreement with CIEMAT and Dr José Carlos Segovia Sanz group for the future development of Gene Therapy in Congenital Dyserythropoietic Anemia in the Neotec2019 application context. Thanks to the patient association ADISCON support!